Grifols Stock News

It is now my pleasure to introduce our first speaker Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel. As a reminder, during today's call we may make forwar

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing people's he

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, the prestigious peer-reviewed scientific journal, today has published the results of Grifols' AMBAR study. This clinical trial was d

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced it has acquired

US and global pharma companies that are working on credible COVID-19 treatments are up massively YTD, often more than 100% and far surpassing performance of general pharma indices.

Grifols SA (GRFS) announced on Monday that it has acquired plasma assets in North America and a plasma facility in Montreal from South Korea’s Green Cross Pharma for a total of $460 million.Shares r

Spanish pharmaceutical company Grifols said on Monday it agreed to buy plasma assets in North America from South Korea's Green Cross for $460 million. Grifols will buy a plasma fractionation plant in

\\- Grifols makes a significant investment to become the only large-scale commercial manufacturer of plasma products in Canada, with a fractionation capacity of 1.

Spanish pharmaceutical company Grifols said on Monday it agreed to buy plasma assets in North America from South Korea's Green Cross for $460 million. Grifols will buy a plasma fractionation plant in

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes

If approved, company’s Roctavian would become first gene therapy for inherited disease Continue reading...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Grifols S.A., its collaborative partner in Europe, has launched TAVLESSE® in Germany and the United Kingdom. It was approved by the Eur

Biogen tops the list Continue reading...

A strong performance today from trade-exposed Korean stocks and currency. U.S. Treasury Secretary Steven Mnuchin said he may further delay tax-filing deadlines and White House adviser Larry Kudlow sa

In this article we will take a look at whether hedge funds think Grifols SA (NASDAQ:GRFS) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hou